Non-small-cell lung cancer: how to manage

RET next-generation sequencing non-small-cell lung cancer pralsetinib selpercatinib tyrosine kinase inhibitors

Journal

Drugs in context
ISSN: 1745-1981
Titre abrégé: Drugs Context
Pays: England
ID NLM: 101262187

Informations de publication

Date de publication:
2022
Historique:
received: 31 01 2022
accepted: 03 06 2022
entrez: 1 8 2022
pubmed: 2 8 2022
medline: 2 8 2022
Statut: epublish

Résumé

Targeted therapy has dramatically changed the history and outcomes of oncogene-addicted non-small-cell lung cancer (NSCLC).

Identifiants

pubmed: 35912003
doi: 10.7573/dic.2022-1-5
pii: dic-2022-1-5
pmc: PMC9281974
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Informations de copyright

Copyright © 2022 Andrini E, Mosca M, Galvani L, Sperandi F, Ricciuti B, Metro G, Lamberti G.

Déclaration de conflit d'intérêts

Disclosure and potential conflicts of interest: The authors declare that they have no conflicts of interest relevant to this manuscript. The International Committee of Medical Journal Editors (ICMJE) Potential Conflicts of Interests form for the authors is available for download at: https://www.drugsincontext.com/wp-content/uploads/2022/06/dic.2022-1-5-COI.pdf

Références

Cancer Discov. 2018 Dec;8(12):1529-1539
pubmed: 30257958
Cancer Discov. 2018 Jul;8(7):836-849
pubmed: 29657135
J Thorac Oncol. 2018 Jan;13(1):27-45
pubmed: 29128428
Br J Cancer. 2014 Mar 18;110(6):1571-8
pubmed: 24504365
Ann Oncol. 2020 Dec;31(12):1725-1733
pubmed: 33007380
Ann Oncol. 2021 Mar;32(3):337-350
pubmed: 33455880
Genes Chromosomes Cancer. 2022 May;61(5):244-260
pubmed: 34997651
N Engl J Med. 2018 May 31;378(22):2078-2092
pubmed: 29658856
Cancer Lett. 2013 Oct 28;340(1):97-103
pubmed: 23856031
N Engl J Med. 2018 Jun 14;378(24):2288-2301
pubmed: 29863955
Clin Cancer Res. 2020 Jun 1;26(11):2615-2625
pubmed: 32034073
Nat Med. 2012 Feb 12;18(3):378-81
pubmed: 22327623
Mod Pathol. 2015 Apr;28(4):468-79
pubmed: 25234288
Mol Cancer Ther. 2011 Dec;10(12):2298-308
pubmed: 21926191
Ann Oncol. 2019 Aug 1;30(8):1321-1328
pubmed: 31125062
Clin Cancer Res. 2016 Sep 15;22(18):4585-93
pubmed: 27225694
Lancet Oncol. 2021 Feb;22(2):198-211
pubmed: 33476593
Lung Cancer (Auckl). 2019 Mar 20;10:27-36
pubmed: 30962732
J Clin Oncol. 2017 May 1;35(13):1403-1410
pubmed: 28447912
Ann Oncol. 2020 Jun;31(6):807-814
pubmed: 32171752
Ann Oncol. 2017 Jul 1;28(suppl_4):iv1-iv21
pubmed: 28881918
Ann Oncol. 2016 Jul;27(7):1286-91
pubmed: 27056998
Nature. 2014 Jul 31;511(7511):543-50
pubmed: 25079552
Clin Cancer Res. 2020 Dec 1;26(23):6102-6111
pubmed: 32665298
Lung Cancer. 2016 Nov;101:16-21
pubmed: 27794403
Nat Rev Cancer. 2014 Mar;14(3):173-86
pubmed: 24561444
J Hematol Oncol. 2021 Mar 26;14(1):50
pubmed: 33771190
Future Oncol. 2021 Mar;17(7):763-773
pubmed: 33150799
Ann Oncol. 2017 Feb 1;28(2):292-297
pubmed: 27803005
Lancet Oncol. 2016 Dec;17(12):1653-1660
pubmed: 27825636
Lancet. 2021 Aug 7;398(10299):535-554
pubmed: 34273294
JAMA Oncol. 2021 May 1;7(5):677-678
pubmed: 33538783
JCO Precis Oncol. 2019;3:
pubmed: 31192313
Clin Cancer Res. 2019 Aug 1;25(15):4691-4700
pubmed: 30988079
Crit Rev Oncol Hematol. 2020 Dec;156:103119
pubmed: 33053439
ESMO Open. 2020 Oct;5(5):e000799
pubmed: 33097651
J Thorac Oncol. 2021 May;16(5):798-806
pubmed: 33588111
BMC Cancer. 2015 Mar 23;15:171
pubmed: 25881079
Lung Cancer. 2019 Dec;138:124-130
pubmed: 31710864
Nat Rev Clin Oncol. 2018 Mar;15(3):151-167
pubmed: 29134959
Lung Cancer. 2015 Sep;89(3):357-9
pubmed: 26187428
N Engl J Med. 2020 Aug 27;383(9):813-824
pubmed: 32846060
J Thorac Oncol. 2014 Nov;9(11):1714-9
pubmed: 25436805
Cancer Discov. 2016 Oct;6(10):1118-1133
pubmed: 27432227
J Clin Oncol. 2008 Jul 20;26(21):3552-9
pubmed: 18506026
Chest. 2013 May;143(5 Suppl):e278S-e313S
pubmed: 23649443
Oncologist. 2009 Apr;14(4):378-90
pubmed: 19349511
Front Med (Lausanne). 2021 Jan 21;7:562480
pubmed: 33553195
J Clin Oncol. 2012 Dec 10;30(35):4352-9
pubmed: 23150706
N Engl J Med. 2020 Oct 29;383(18):1711-1723
pubmed: 32955177
J Thorac Oncol. 2017 Feb;12(2):403-407
pubmed: 27765535
J Thorac Oncol. 2018 Nov;13(11):e226-e227
pubmed: 30368414
J Thorac Oncol. 2016 Jan;11(1):122-7
pubmed: 26762747
J Thorac Oncol. 2020 Apr;15(4):541-549
pubmed: 31988000
Oncol Ther. 2020 Dec;8(2):333-339
pubmed: 32700042
Lancet Respir Med. 2017 Jan;5(1):42-50
pubmed: 27825616
J Thorac Oncol. 2018 Oct;13(10):1595-1601
pubmed: 30017832
Cancers (Basel). 2021 Sep 01;13(17):
pubmed: 34503226
Ann Oncol. 2018 Aug 1;29(8):1869-1876
pubmed: 29912274
Clin Cancer Res. 2021 Jan 1;27(1):34-42
pubmed: 33082208
Lancet Oncol. 2021 Jul;22(7):959-969
pubmed: 34118197

Auteurs

Elisa Andrini (E)

Department of Experimental, Diagnostic & Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Mirta Mosca (M)

Department of Experimental, Diagnostic & Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Linda Galvani (L)

Department of Experimental, Diagnostic & Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Francesca Sperandi (F)

Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Biagio Ricciuti (B)

Department of Experimental, Diagnostic & Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Department of Medicine, Harvard Medical School, Boston, MA, USA.

Giulio Metro (G)

Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy.

Giuseppe Lamberti (G)

Department of Experimental, Diagnostic & Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Classifications MeSH